Retatrutide Weight Loss Peptide – 10 mg Box by ZPHC

What is Retatrutide by ZPHC?

Retatrutide is an advanced peptide known as a "Triple Agonist", targeting three key hormone receptors in the body: GLP-1, GIP, and Glucagon receptors. This unique mechanism makes it one of the most promising peptides currently available for weight management. Manufactured by ZPHC (Zhengzhou Pharmaceutical), a company recognized for its strict pharmaceutical-grade manufacturing standards under the PROFI-LINE series, this product contains a total of 10 mg of Retatrutide (5 sterile vials × 2 mg each), packaged in a nitrogen-filled sterile environment to ensure maximum purity and stability. The package also includes one 11 ml vial of Bacteriostatic Diluent for reconstitution.

Purpose of Using ZPHC Retatrutide

Retatrutide peptide is primarily used to support several body composition and metabolic goals, including:

• Effective Weight Loss: Helps promote fat breakdown and supports the reduction of stored body fat.
• Powerful Appetite Suppression: Reduces hunger while increasing feelings of fullness through its activity on GLP-1 receptors.
• Improved Metabolism: Activates glucagon receptors to increase energy expenditure and calorie burning, even during rest.

• Blood Sugar Regulation: Helps improve insulin sensitivity and supports healthy blood glucose management.

How to Use ZPHC Retatrutide (Preparation & Injection)

Important Medical Notice: The following information is provided for educational purposes only and is based on general peptide handling guidelines. The product packaging clearly states that it is intended "For Professional Use Only." Dosage and administration should always be determined by a qualified healthcare professional to ensure safety and minimize potential side effects.

Retatrutide is a long-acting peptide that is generally administered once per week. Below are the general preparation and administration guidelines:

1. Reconstitution

Each ZPHC package contains lyophilized Retatrutide powder (2 mg per vial) along with Bacteriostatic Water for reconstitution.

• Disinfection: Wash your hands thoroughly and disinfect the rubber stoppers of both the peptide vial and the bacteriostatic water using an alcohol swab.
• Draw the Diluent: Using a sterile insulin syringe, withdraw the prescribed amount of bacteriostatic water (commonly 1 ml or 2 ml depending on the desired concentration).
• Mixing: Slowly inject the bacteriostatic water into the Retatrutide vial. Direct the stream against the inside wall of the vial rather than directly onto the powder to minimize peptide degradation.
• Dissolving: Do not shake the vial. Instead, gently swirl the vial until the powder has completely dissolved and the solution becomes clear.

2. Administration

Retatrutide is administered as a subcutaneous injection and should not be injected intramuscularly or intravenously.

• Preferred Injection Sites:
  • Abdomen (avoiding the area immediately around the navel).
  • Front of the thigh.
  • Back of the upper arm (if administered by another person).
• Site Rotation: Rotate injection sites with each dose to reduce the risk of skin irritation or lipodystrophy.
• Injection Technique: Clean the injection site with an alcohol swab and allow it to dry. Pinch a fold of skin gently, insert the insulin needle at a 45° or 90° angle, and inject the dose slowly.

3. Dosage Protocol

Multi-receptor weight management peptides typically follow a dose titration protocol to reduce gastrointestinal side effects such as nausea.

• Starting Dose: Healthcare professionals usually begin with a low weekly dose (such as 0.5 mg or 1 mg) for approximately four weeks to allow the body to adapt.
• Target Dose: The dosage is gradually increased every month based on individual response and tolerability until the desired maintenance dose is reached.
• (Note: Each ZPHC vial contains 2 mg of Retatrutide. Accurate dose measurement depends on the volume of bacteriostatic water used during reconstitution and should be calculated carefully when using an insulin syringe.)

4. Storage After Reconstitution

• Before Reconstitution: Store refrigerated at 2–8°C (36–46°F).
• After Reconstitution: Keep the reconstituted vial refrigerated at all times and use it within the recommended stability period (typically between 14–28 days). Protect from direct light.

Contraindications of ZPHC Retatrutide

For safety reasons, Retatrutide should not be used under the following conditions:

• Pregnancy & Breastfeeding: Contraindicated during pregnancy and while breastfeeding.
• Personal or Family History of Thyroid Cancer: Individuals with a history of Medullary Thyroid Carcinoma (MTC) should not use this product.
• Severe Gastrointestinal Disorders: Including gastroparesis or previous pancreatitis.
• Type 1 Diabetes: Consultation with a healthcare professional is required, as this peptide is primarily intended for obesity and Type 2 diabetes management.
• Note: This product is intended For Professional Use Only and should be used under qualified medical supervision.

Frequently Asked Questions About ZPHC Retatrutide

1. How should ZPHC Retatrutide be stored?

To preserve peptide quality and potency, store the product in a refrigerator as indicated on the packaging. Avoid excessive heat and do not freeze.

2. What does the package include?

The package contains:

• Five sterile vials, each containing 2 mg of lyophilized Retatrutide (10 mg total).
• One 11 ml vial of sterile Bacteriostatic Diluent for reconstitution.

3. When can results from Retatrutide be expected? Results vary depending on diet, physical activity, and individual response. Many users report noticeable appetite reduction within the first few days, followed by gradual and consistent weight loss during the following weeks.
4. Can Retatrutide be used with other products? Yes. It may be combined with supplements such as vitamins or protein powders. However, using other weight-loss medications or peptides acting on the same receptors (such as Semaglutide or Tirzepatide) simultaneously is generally discouraged unless specifically directed by a healthcare professional due to the increased risk of adverse effects.

Important Disclaimer

The information provided on this website is for informational purposes only and does not constitute medical advice or replace consultation with a qualified healthcare professional. This website does not promote the use of these products as therapeutic drugs or dietary supplements unless approved by the relevant regulatory authorities. Please note that this product is intended for research and advanced use only and should be used only under appropriate medical supervision.

The purchaser is solely responsible for complying with all applicable laws and regulations issued by the Egyptian Ministry of Health and the Egyptian Drug Authority regarding the possession, distribution, or use of these products. By purchasing, the buyer acknowledges that any use will be limited to legally permitted research purposes.

The website and its management shall not be held liable for any unlawful use or any use inconsistent with the intended purpose stated above. The purchaser assumes full responsibility for ensuring compliance with all applicable legal and medical requirements.